Services

Our integrated global facilities support a broad range of dosage forms, including bioavailability enhancing dosage forms, oral solid dosage forms, liquid dosage forms, and pediatric formulations, with flexible packaging options.
Leveraging advanced formulation technologies and specialized platforms, we optimize drug stability, bioavailability, and patient compliance from laboratory scale to commercial production.
All our commercial products are delivered with assured quality, full regulatory compliance, and reliable global supply.

We offer comprehensive custom synthesis services for small molecules, intermediates, and APIs. Our support spans the entire development lifecycle—from designing and selecting synthetic routes, process development, and toxicology batch production, to analytical method development and validation, stability studies, and GMP manufacturing for Phase I–III clinical trials. We also provide seamless scale-up and commercial production capabilities, with volumes ranging from milligrams to 1,000 tons. We also assist in preparing CTD documents for regulatory filings, including IND and NDA submissions. Our advanced technologies and flexible production platforms ensure high-quality, reproducible, and compliant compounds to meet both research and commercial needs.

With over 40 years of experience, we provide safe, high-quality, and cost-effective commercial drug products to global partners. Our cGMP-compliant facilities are highly automated and equipped to handle a broad spectrum of dosage forms—including lyophilized powder injections, small-volume liquid injections, tablets, capsules, syrups, granules, ointments, and pediatric formulations. We offer flexible packaging solutions to meet diverse market needs. Backed by our expert registration team, we also support regulatory submissions such as CTD and ACTD dossiers, ensuring a compliant and dependable supply to global markets.

With its leading position in Structure-Based Drug Discovery (SBDD), Viva provides state-of-the-art drug research and development services to global biotechnology and pharmaceutical clients for their preclinical, innovative drug discovery programs. We cover the all-around needs of our clients for their early drug research and development, including protein expression, purification and structure determination, hits screening, therapeutic antibody discovery, antibody expression and production, Bioassay, artificial Intelligence drug discovery(AIDD) and computer-aided drug design (CADD), medicinal chemistry and custom synthesis in vivo pharmacology, ADME, and PK studies.

To learn more about CRO Drug R&D Services

Please visit Viva's website

We provide global partners with a one-stop CDMO solution across the entire life cycle of new drugs, covering small molecule APIs and Finished Dosage Forms from preclinical development to commercial supply.
Supported by over 200 experienced scientists across R&D centers in Shanghai, Taizhou, and Ningbo, we excel in process development, scale-up, and regulatory submissions, including IND and NDA filings.
We have a proven 13-year track record of passing on-site cGMP inspections conducted by leading global regulatory authorities including the FDA, EDQM, NMPA, PMDA, ANVISA and WHO. We are also proud to have passed EHS and PSCI audits by major multinational pharmaceutical companies.

To learn more about CDMO R&D and Production Services

Please visit Langhua's website